Hunter syndrome with its typical heart: a close mimic to rheumatic heart

Jagadesh Madireddi1, Sarada P1, R K Shetty2

  • 1Department of Internal Medicine, Kasturba Medical College, Manipal, Karnataka, India.

BMJ Case Reports
|May 9, 2015
PubMed

Insights

Hunter syndrome, a rare genetic disorder, presents with multisystem involvement and cardiac issues. Early diagnosis and enzyme replacement therapy significantly improve patient quality of life.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Mucopolysaccharidoses (MPS) are rare genetic lysosomal storage disorders.
  • Hunter syndrome (MPS II) is characterized by a deficiency in iduronate-2-sulfatase, leading to glycosaminoglycan accumulation.
  • Multisystemic manifestations include skeletal deformities, coarse facial features, and cardiac valve abnormalities.

Observation:

  • A 24-year-old male presented with dyspnea (New York Heart Association grade 3), dwarfism, coarse facial features, and multiple skeletal deformities (cubitus valgus, claw hand, genu valgus, hallux valgus, equinovarus).
  • Systemic examination revealed cardiomegaly, a pansystolic mitral regurgitation murmur, hepatosplenomegaly, and normal intelligence.
  • Echocardiography demonstrated thickened mitral and aortic valves with moderate mitral regurgitation.

Findings:

  • Clinical presentation and echocardiographic findings suggested a storage disorder, specifically mucopolysaccharidosis, due to characteristic cardiac involvement.
  • Further investigations confirmed the diagnosis of Hunter syndrome (MPS II).

Implications:

  • Hunter syndrome requires consideration in young patients presenting with multisystemic involvement and cardiac abnormalities.
  • Availability of enzyme replacement therapy (ERT) underscores the importance of early diagnosis and prompt, multidisciplinary treatment.
  • Timely intervention can significantly improve the quality of life for individuals with Hunter syndrome.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
585
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
786
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
916